Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Charles River Labs Intl buy Barclays PLC

Charles River Labs Intl
Start price
€149.30
02.10.25 / 50%
Target price
€166.12
02.10.26
Performance (%)
0.57%
Price
€150.15
16.04.26
Summary
This prediction is currently active. Since the start of the prediction for Charles River Labs Intl the price has only changed by 0.57%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Charles River Labs Intl 2.632% 2.632%
iShares Core DAX® 0.789% 1.975%
iShares Nasdaq 100 4.226% 4.344%
iShares Nikkei 225® 3.285% 6.991%
iShares S&P 500 2.496% 2.759%

Comments by Barclays_PLC for this prediction

In the thread Charles River Labs Intl diskutieren
Prediction Buy
Perf. (%) 0.57%
Target price 166.121
Change
Ends at 02.10.26

Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $195.00 price target on the stock, up previously from $165.00.
Ratings data for CRL provided by MarketBeat

Barclays PLC 
0
Report Share
02.10.25

Stopped prediction by Barclays_PLC for Charles River Labs Intl

buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€149.35
06.11.25
€182.47
06.11.26
0.54%
16.04.26

Barclays PLC 
06.11.25 50%